Compare · DVA vs VMD
DVA vs VMD
Side-by-side comparison of DaVita Inc. (DVA) and Viemed Healthcare Inc. (VMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DVA and VMD operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- DVA is the larger of the two at $15.12B, about 32.0x VMD ($472.7M).
- Over the past year, DVA is up 64.2% and VMD is up 84.2% - VMD leads by 20.0 points.
- VMD has hit the wire 2 times in the past 4 weeks while DVA has been quiet.
- DVA has more recent analyst coverage (13 ratings vs 1 for VMD).
- Company
- DaVita Inc.
- Viemed Healthcare Inc.
- Price
- $235.50+1.28%
- $12.35+0.24%
- Market cap
- $15.12B
- $472.7M
- 1M return
- +18.58%
- +21.98%
- 1Y return
- +64.22%
- +84.19%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 0
- 2
- Recent ratings
- 13
- 1
DaVita Inc.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2020, it provided dialysis and administrative services in the United States through a network of 2,816 outpatient dialysis centers serving approximately 204,200 patients; and operated 321 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 36,700 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Viemed Healthcare Inc.
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen therapy, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and other respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.
Latest DVA
- Chief Legal & Pub. Affairs Off Waters Kathleen Alyce sold $3,210,377 worth of shares (15,405 units at $208.40) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 109,194 units (SEC Form 4)
- Chief Executive Officer Rodriguez Javier sold $14,532,108 worth of shares (69,407 units at $209.38), decreasing direct ownership by 8% to 840,408 units (SEC Form 4)
- SEC Form 11-K filed by DaVita Inc.
- DaVita Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Director Yale Phyllis R gifted 5,038 shares, decreasing direct ownership by 35% to 9,525 units (SEC Form 4)
- Director Pullin Dennis W was granted 250 shares, increasing direct ownership by 10% to 2,671 units (SEC Form 4)
- Director Schoppert Wendy Lee was granted 250 shares (SEC Form 4)
- Director Moore Gregory J. was granted 250 shares, increasing direct ownership by 3% to 7,813 units (SEC Form 4)
- Director Arway Pamela M was granted 250 shares, increasing direct ownership by 0.94% to 26,945 units (SEC Form 4)
- Director Yale Phyllis R was granted 250 shares, increasing direct ownership by 2% to 14,563 units (SEC Form 4)
Latest VMD
- Chief Medical Officer Frazier William exercised 10,000 shares at a strike of $1.81 and sold $117,200 worth of shares (10,000 units at $11.72) (SEC Form 4)
- Director Smokoff Timothy sold $229,967 worth of shares (20,000 units at $11.50), decreasing direct ownership by 21% to 75,518 units (SEC Form 4)
- Viemed Healthcare Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Viemed Healthcare Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 10-Q filed by Viemed Healthcare Inc.
- Viemed Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Viemed Healthcare Announces First Quarter 2026 Financial Results
- SEC Form DEF 14A filed by Viemed Healthcare Inc.
- SEC Form DEFA14A filed by Viemed Healthcare Inc.
- Viemed Healthcare Announces First Quarter 2026 Earnings Conference Call Details